Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

Objective: This phase 3, laboratory classroom study assessed the efficacy and safety of methylphenidate hydrochloride extended-release chewable tablets (MPH ERCT) compared with placebo in children with attention-deficit/hyperactivity disorder (ADHD). Methods: Following a 6-week, open-label, dose-opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Wigal, Sharon B., Childress, Ann, Berry, Sally A., Belden, Heidi, Walters, Faith, Chappell, Phillip, Sherman, Nancy, Orazem, John, Palumbo, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651935/
https://www.ncbi.nlm.nih.gov/pubmed/28557548
http://dx.doi.org/10.1089/cap.2016.0177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5651935/
https://www.ncbi.nlm.nih.gov/pubmed/28557548
http://dx.doi.org/10.1089/cap.2016.0177

Ejemplares similares